AzTrials
AzTrials

Subacute StrokeSYNCOMOTNCT03009773

The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?

A study testing rehabilitation multitasking walking. and Traditional walking rehabilitation in people with Subacute Stroke, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Stroke is the leading cause of severe disability in adults. The first cause of alterations in the quality of life and autonomy in these patients are disorders of walking and the balance. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Subacute Stroke
What is being tested?
rehabilitation multitasking walking. and Traditional walking rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteFrance
Study dates
12 May 2017to 29 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Major: age between 18 and 90 years
  • Hospitalized for ischemic or hemorrhagic hemispheric stroke confirmed by CT or MRI <6months
  • walking disorder with the possibility of walking 10 meters with or without technical assistance (speed <1.2m / s)
  • verbal understanding with complex orders
  • Affiliates to social security

Who cannot join

  • Brainstem stroke or cerebellar
  • Hypoacusia annoying understanding
  • Visual gene embarrassing awarding
  • severe aphasia: no understanding of complex orders
  • neurological or musculoskeletal history affecting walking
  • Participation in interventional research protocol in motor rehabilitation of the lower limb or cognitive
  • Patient under guardianship or deprived of liberty
  • pregnant women, parturient women or lactating (art L.1121-5)

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Amiens Picardie

    Amiens, Picardie, 80054

Other trials in France

About this study

Stroke is the leading cause of severe disability in adults. The first cause of alterations in the quality of life and autonomy in these patients are disorders of walking and the balance. They are the leading cause of falls responsible for important medical, surgical and economic complications as well as a reactionary social isolation.

The techniques of rehabilitation of walking to the subacute phase of a stroke are usually based on automatic walking.Off walking is a complex activity usually performed in everyday life in association with multiple tasks. It is therefore interesting to re-educate walking in dual task or even in multitasking.

Conditions
Subacute Stroke
Being tested
rehabilitation multitasking walking., Traditional walking rehabilitation
Keywords
subacute stroke, multitasking rehabilitation, walking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rehabilitation multitasking walking.Other

    rehabilitation multitasking walking.

  • Traditional walking rehabilitationOther

    Traditional walking rehabilitation

Study groups in NCT03009773
Study groupRoleWhat they receive
multitasking walkingExperimentalMultitasking Group: rehabilitation multitasking walking.
Receives: Other: rehabilitation multitasking walking.
walking simple taskActive comparatorSimple task group : Traditional walking rehabilitation
Receives: Other: Traditional walking rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure walking speed

    Speed of the simple task of walking 10 meters testing.

    Measured: 6 months

Secondary outcomes (9)
  1. Description of different types of walking disorders and balance in the subacute phase of stroke

    Currently no clinical scale exists in the literature at our knowledge. The walk of the patients will be qualitatively analyzed by the investigator in order to measure the prevalence of the different clinical categories of walking disorders according to their semiological characteristics

    Measured: inclusion

  2. Score neuromotor the lower limb

    Score neuromotor the lower limb: Fugl Meyer

    Measured: 6 months

  3. Dynamic equilibrium to TUG single and double cognitive task

    Dynamic equilibrium to TUG single and double cognitive task

    Measured: 6 months

  4. Walking speed double cognitive task

    Walking speed double cognitive task

    Measured: 6 months

  5. Executive functions: a battery of neuropsychological

    Executive functions: a battery of neuropsychological

    Measured: 6 months

  6. Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT

    Autonomy: FUNCTIONAL INDEPENDENCE MEASUREMENT

    Measured: 6 months

  7. EVA Quality of life

    EVA (Visual Analogic Scale) quality of life

    Measured: 6 months

  8. Correlation of cognitive gains with the gain of the walking speed of 10 meters

    Correlation of cognitive gains with the gain of the walking speed of 10 meters

    Measured: 6 months

  9. anatomoclinical correlations

    Lesion score of gray matter and white matter (Volumetry on sequences 3DT1 and Flair) Cerebral

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jan 2017 (estimated)
  2. Study start12 May 2017
  3. Primary completion29 Jun 2020
  4. Study completion29 Jun 2020

Why it stopped: Recruitment difficulties

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03009773
Sponsor's protocol ID
PI2016_843_0007
Acronym
SYNCOMOT
Status last verified
Jun 2026
First submitted
14 Nov 2016
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Tasseel-Ponche S, Roussel M, Toba MN, Sader T, Barbier V, Delafontaine A, Meynier J, Picard C, Constans JM, Schnitzler A, Godefroy O, Yelnik AP. Dual-task versus single-task gait rehabilitation after stroke: the protocol of the cognitive-motor synergy multicenter, randomized, controlled superiority trial (SYNCOMOT). Trials. 2023 Mar 8;24(1):172. doi: 10.1186/s13063-023-07138-x.

    PubMed 36890548

Questions about this trial

What is this clinical trial studying?

A study testing rehabilitation multitasking walking. and Traditional walking rehabilitation in people with Subacute Stroke, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Recruitment difficulties). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure walking speed (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03009773, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in